Featured Research

from universities, journals, and other organizations

Donated human stool safely and effectively treats C. difficile infections, study suggests

Date:
October 20, 2012
Source:
Henry Ford Health System
Summary:
A novel therapy that uses donated human stool to treat the deadly and contagious C.diff infection is safe and highly effective, according to a new study. The healthy stool, when mixed with warm tap water and administered, helps to re-establish the normal intestinal flora in the patient’s gastrointestinal tract, researchers say. Researchers found that 43 of 49 patients recovered swiftly after treatment and had no adverse complications from C.difficile three months later.

A novel therapy that uses donated human stool to treat the deadly and contagious C.difficile infection is safe and highly effective, according to a Henry Ford Hospital study.

Researchers found that 43 of 49 patients recovered swiftly after treatment and had no adverse complications from C.diff three months later. Treatment is performed either through a nasogastric tube or colonscopy on an outpatient or inpatient basis.

Mayur Ramesh, M.D., a Henry Ford Infectious Diseases physician and senior author of the study, says the treatment, while appearing unconventional, has striking results.

"More than 90 percent of the patients in our study were cured of their C.diff infection," says Dr. Ramesh. "This treatment is a viable option for patients who are not responding to conventional treatment and who want to avoid surgery."

The study was presented October 19 at the annual Infectious Diseases Society of America meeting in San Diego.

In their study, researchers evaluated 49 patients who contracted Clostridium difficile, or C.diff, a germ that causes diarrhea and other intestinal problems and is linked to 14,000 deaths annually. Symptoms include water diarrhea, fever, loss of appetite, nausea and abdominal pain and tenderness. C.diff occurs in patients taking antibiotics, and can spread from person-to-person contact or from touching contaminated equipment and objects like door knobs.

Patients with a C.diff infection are typically treated with the antibiotics metronidazole or vancomycin. However, surgery could be required to remove the infected part of the intestines. In its study, Henry Ford treated patients between May 2010 and June 2012 with a therapy called intestinal microbiota transplantation (IMT), using donated stool from a healthy family member.

Dr. Ramesh says the healthy stool, when mixed with warm tap water and administered, helps to re-establish the normal intestinal flora in the patient's gastrointestinal tract. Intestinal flora is healthy bacteria that stimulates the immune system and aids the digestion and absorption of food.

"Patients who receive treatment through a nasogastric tube don't taste or smell the stool mixture as it's administered," Dr. Ramesh says. "Patients often resume their diet within a couple hours and are feeling better within 24 hours."

Of the 49 patients, 43 fully recovered, four died of causes unrelated to C.diff, one had intestinal surgery and one had no improvement.

The study was funded by Henry Ford Hospital.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Donated human stool safely and effectively treats C. difficile infections, study suggests." ScienceDaily. ScienceDaily, 20 October 2012. <www.sciencedaily.com/releases/2012/10/121020162445.htm>.
Henry Ford Health System. (2012, October 20). Donated human stool safely and effectively treats C. difficile infections, study suggests. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2012/10/121020162445.htm
Henry Ford Health System. "Donated human stool safely and effectively treats C. difficile infections, study suggests." ScienceDaily. www.sciencedaily.com/releases/2012/10/121020162445.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins